Eduarda Grinsztejn Joao
Cleveland, OHNPI 1477115723
Payments from drug & device makers
$1,730in general payments, 2019–2025
Across 74 payments — averaging $23.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$243
- Takeda Pharmaceuticals U.S.A., Inc.$122
- Novartis$116
- Pfizer$110
- Incyte Corporation$107
- Eisai Inc.$105
- plus $928 from 19 others
What the payments were for
- Food & beverage$1,730100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 5 | $243 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $122 |
| Novartis | 7 | $116 |
| Pfizer | 6 | $110 |
| Incyte Corporation | 5 | $107 |
| Eisai Inc. | 5 | $105 |
| AbbVie | 4 | $104 |
| Merck | 4 | $89 |
| AstraZeneca | 4 | $82 |
| Amgen | 3 | $72 |
| Genmab U.S., Inc. | 3 | $64 |
| Astellas Pharma US Inc | 2 | $64 |
| Blueprint Medicines Corporation | 2 | $62 |
| Gilead(2 entities) | 3 | $58 |
| Bristol Myers Squibb | 3 | $51 |
| AVEO Pharmaceuticals, Inc. | 2 | $47 |
| EMD Serono, Inc. | 1 | $38 |
| Genentech USA, Inc. | 2 | $33 |
| Array Biopharma Inc | 2 | $33 |
| Lilly USA, LLC | 1 | $27 |
| Pharmaessentia USA Corporation | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Jazz Pharmaceuticals Inc. | 1 | $22 |
| Boehringer Ingelheim | 1 | $22 |
| Seagen Inc. | 1 | $14 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.